致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human LILRB2/CD85d/ILT4, hFc-tag
目录号 NBL-240675
别名 LILRB2/CD85d/ILT4; CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10
外观 see COA
分子量 Gln22-His458
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q8N423-1
备注2
目录号 规格 价格 库存状态  
NBL-240675-100ug 100ug Inquire Inquire
NBL-240675-1mg 1mg Inquire Inquire
NBL-240675-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human LILRB2/CD85d/ILT4, hFc-tag


Catalog#:

NBL-240675


Description:

NebuSelect™ Recombinant Human LILRB2/CD85d/ILT4, hFc-tag(Cat#NBL-240675) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln22-His458.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 74.1 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.


Target Name:

LILRB2/CD85d/ILT4; CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10


Target Information:

The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles.


Amino Acid Sequence: 

Gln22-His458


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品